GSK Korea's Establishment of Vaccine Production Facility Still Under Discussion

In reaction to a number of reports recently made by the domestic daily newspapers that GlaxoSmithKline (GSK) Korea would establish a large-scale vaccine production facility in the Gyeonggi province, the company stated that no such decision has yet been approved by the GSK corporate headquarter.

According to the company spokesperson, a series of visits made by Provincial Governor Sohn Hak-kyu...